TP53 and lung cancer: Recently, a retrospective analysis of 7788 lung cancer patients who performed exome sequencing revealed the presence of germline pathogenic variant in 15% of cases, a higher prevalence than previously described for BRCA2, CHEK2, ATM, TP53, BRCA1, and EGFR [10,11].